Allen Bloom serves as Executive at CYTOGEN CORP, where they oversee executive responsibilities. Since joining the company, Allen Bloom has executed 17 insider transactions totaling $2.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 6, 2011 involved receiving (via award) 17,308 shares valued at $18.0K.
Allen Bloom currently holds 332,015 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allen Bloom has been a net buyer of CYTO stock. They have purchased $2.7K and sold $0 worth of shares.
Allen Bloom's most recent insider trade was on Jul 6, 2011, when they sold 17,308 shares at $1.04 per share.
Get notified when new Form 4 filings are submitted
| 10,000 |
| $0.66 |
| Discretionary |
| May 1, 2011 | UGNE | $0 | Award | 10,000 | $N/A | Discretionary |
| Jan 5, 2011 | UGNE | $18.0K | Award | 23,077 | $0.78 | Discretionary |
| Dec 17, 2010 | UGNE | $70.5K | Option Exercise | 150,000 | $0.47 | Discretionary |
| Jul 6, 2010 | UGNE | $18.0K | Award | 23,684 | $0.76 | Discretionary |
| Jun 15, 2010 | UGNE | $0 | Award | 20,000 | $N/A | Discretionary |
| May 1, 2010 | UGNE | $0 | Award | 10,000 | $N/A | Discretionary |
| Jan 6, 2010 | UGNE | $18.0K | Award | 25,000 | $0.72 | Discretionary |
| Jul 6, 2009 | UGNE | $9.0K | Award | 6,429 | $1.40 | Discretionary |
| May 1, 2009 | UGNE | $0 | Award | 10,000 | $N/A | Discretionary |
| Jan 6, 2009 | UGNE | $9.0K | Award | 15,517 | $0.58 | Discretionary |
| Nov 18, 2008 | UGNE | $4.4K | Option Exercise | 10,000 | $0.44 | Discretionary |
| May 8, 2008 | CYTO | $0 | Disposition | 10,000 | $N/A | Discretionary |
| May 8, 2008 | CYTO | $0 | Disposition | 2,000 | $N/A | Discretionary |
| Mar 14, 2008 | RPBC | $2.7K | Purchase | 5,000 | $0.54 | Discretionary |
| Jun 13, 2007 | CYTO | $0 | Award | 10,000 | $N/A | Discretionary |